Skip to main content

What the FDA labels say about taking them together

Darunavir and ethinyl estradiol/ferrous fumarate/levonorgestrel

Ethinyl estradiol/ferrous fumarate/levonorgestrel's FDA label of October 18, 2024 names darunavir in its drug interactions section; the darunavir label PlainMeds reads does not name ethinyl estradiol/ferrous fumarate/levonorgestrel. The ethinyl estradiol/ferrous fumarate/levonorgestrel label: “Significant changes (increase or decrease) in the plasma concentrations of estrogen and/or progestin have been noted in some cases of co-administration with HIV/HCV protease inhibitors and non-nucleoside reverse …”

Check it at the source: the darunavir FDA label on DailyMed (effective August 29, 2025, Janssen Products LP); the ethinyl estradiol/ferrous fumarate/levonorgestrel FDA label on DailyMed (effective October 18, 2024, Xiromed, LLC).

What does the darunavir label say about ethinyl estradiol/ferrous fumarate/levonorgestrel?

Darunavir's label (effective August 29, 2025) does not name ethinyl estradiol/ferrous fumarate/levonorgestrel in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (PREZISTA), Janssen Products LP, effective August 29, 2025 (SPL set 814301f9-c990-46a5-b481-2879a521a16f), via openFDA; the full label on DailyMed

What does the ethinyl estradiol/ferrous fumarate/levonorgestrel label say about darunavir?

Ethinyl estradiol/ferrous fumarate/levonorgestrel label, drug interactions

Significant changes (increase or decrease) in the plasma concentrations of estrogen and/or progestin have been noted in some cases of co-administration with HIV/HCV protease inhibitors and non-nucleoside reverse transcriptase inhibitors (decrease [e.g., nelfinavir, ritonavir, darunavir/ritonavir, (fos)amprenavir/ritonavir, lopinavir/ritonavir, tipranavir/ritonavir, boceprevir, telaprevir, nevirapine and efavirenz] or increase [e.g., indinavir, atazanavir/ritonavir and etravirine]).

Source: FDA drug label (Joyeaux), Xiromed, LLC, effective October 18, 2024 (SPL set 655b2c93-cfae-d44f-c128-c816bbd88e45), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Darunavir generic labelers
1Ethinyl estradiol/ferrous fumarate/levonorgestrel generic labelers
DarunavirEthinyl estradiol/ferrous fumarate/levonorgestrel
Labeled forHIVBirth control
Boxed warningNoYes
Pharmacy cost (NADAC)$1.16 per tablet 600 mg tablet$3.45 per tablet 28 tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?